EGCG

DIETARY_SUPPLEMENT13 trials

Conditions

Alzheimer DiseaseBreast NeoplasmsCancer PatientsCardiovascular DiseasesCognitive DeclineCognitive FunctionDermatitisEpigallocatechin Gallate

Phase 1

Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis

NCT01481818

Shandong Cancer Hospital and InstituteEpigallocatechin Gallate, Radiation Mucositis, Radio Dermatitis

Start: 2011-09-30End: 2022-08-31Target: 15Updated: 2020-04-28

Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer

CompletedNCT05039983

Shandong Cancer Hospital and InstituteEsophageal Obstruction

Start: 2021-08-20End: 2024-01-02Updated: 2024-04-03

Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients

NCT05758571

Shandong Cancer Hospital and InstituteInterstitial Pneumonia, Neoplasms Malignant

Start: 2023-01-05End: 2025-12-31Target: 78Updated: 2023-05-30

Phase 2

Effect of EGCG on the Body's Response to Insulin

WithdrawnNCT00434499

University of Maryland, BaltimoreHypertension, Insulin Resistance, Obesity +1

Start: 2007-02-28End: 2015-12-31Updated: 2022-03-04

Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome (TESFX)

CompletedNCT01855971

Parc de Salut MarFragile X Syndrome

Start: 2013-06-11End: 2015-10-31Updated: 2019-05-10

Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy

NCT02577393

Shandong Cancer Hospital and InstituteEpigallocatechin Gallate, Esophagitis, Lung Neoplasms +1

Start: 2015-04-30End: 2022-08-31Target: 83Updated: 2020-04-28

Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy

NCT02580279

Shandong Cancer Hospital and InstituteBreast Neoplasms, Dermatitis, Epigallocatechin Gallate +1

Start: 2014-12-31End: 2019-10-31Target: 68Updated: 2019-04-05

Effect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury Patients

CompletedNCT02731495

National Nutrition and Food Technology InstituteTraumatic Brain Injury

Start: 2015-03-31End: 2016-01-31Updated: 2016-06-07

Study of of Oxygen Nebulized Inhalation EGCG in Cancer Patients With New Coronary Pneumonia

CompletedNCT06924749

Shandong Cancer Hospital and InstituteCancer Patients, Pneumonia, Interstitial

Start: 2023-06-05End: 2024-07-02Updated: 2025-11-28

Phase 4

Effects of Epigallocatechin Gallate (EGCG) in Healthy, Young Adults

CompletedNCT00981292

Northumbria UniversityCognitive Function, Mood

Start: 2009-08-31End: 2009-12-31Updated: 2012-04-13

Unknown Phase

The Role of Tea Catechins and Caffeine in Relation to Energy Metabolism

CompletedNCT00611416

University of CopenhagenObesity

Start: 2005-11-30End: 2006-02-28Updated: 2009-02-09

Improvement of Endothelial Function by EGCG

CompletedNCT01662232

Charite University, Berlin, GermanyCardiovascular Diseases

Start: 2012-08-31End: 2013-09-30Updated: 2016-02-03

Prevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal Intervention

CompletedNCT03978052

Parc de Salut MarAlzheimer Disease, Cognitive Decline

Start: 2019-10-30End: 2023-06-28Updated: 2024-03-15

Frontiers in Nutrition2026-09-04

Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer

BMC Cancer2024-04-1736 citations

Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial

Scientific Reports2023-08-2418 citations

Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy

JAMA Dermatology2022-06-0163 citations

Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study

Frontiers in Oncology2021-06-1014 citations

A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome.

2019-03-2521 citations

Epigallocatechin-3-gallate treatment to promote neuroprotection and functional recovery after nervous system injury

Neural Regeneration Research2015-01-017 citations